The role of MRO as an M2 macrophage-associated gene in non-small cell lung cancer: insights into immune infiltration, prognostic significance, and therapeutic implications

Abstract Background Non-small cell lung cancer (NSCLC), including lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), is influenced by tumor-immune interactions. M2 macrophages play a significant role in the tumor microenvironment. This study explores the role of MRO, an M2 macrophag...

Full description

Saved in:
Bibliographic Details
Main Authors: Yue Gu, Miaosen Zheng, Jing Xie
Format: Article
Language:English
Published: Springer 2025-01-01
Series:Discover Oncology
Subjects:
Online Access:https://doi.org/10.1007/s12672-025-01817-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585677123878912
author Yue Gu
Miaosen Zheng
Jing Xie
author_facet Yue Gu
Miaosen Zheng
Jing Xie
author_sort Yue Gu
collection DOAJ
description Abstract Background Non-small cell lung cancer (NSCLC), including lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), is influenced by tumor-immune interactions. M2 macrophages play a significant role in the tumor microenvironment. This study explores the role of MRO, an M2 macrophage-associated gene, in NSCLC, focusing on immune infiltration, prognostic significance, and therapeutic potential. Methods NSCLC samples from The Cancer Genome Atlas (TCGA) were analyzed using the CIBERSORT algorithm to quantify immune cell compositions. Differential gene expression and correlation studies examined MRO’s association with M2 macrophages. Univariate Cox regression and Kaplan–Meier analyses assessed prognostic significance. Single-cell RNA sequencing data from TISCH2 evaluated MRO expression in different cell types. The ESTIMATE algorithm analyzed correlations between MRO expression and immune scores, while TIDE and Submap analyses predicted immunotherapy responses. Results MRO was highly expressed in NSCLC, particularly in LUAD and LUSC, and associated with M2 macrophages. MRO correlated with key immune pathways, including TNFα signaling via NFκB, inflammatory response, and IL6 JAK STAT3 signaling. High MRO expression correlated with poorer overall survival (OS) and disease-specific survival (DSS). Single-cell analysis confirmed MRO expression in macrophages. The ESTIMATE algorithm showed positive correlations between MRO expression and immune scores. TIDE and Submap analyses suggested low MRO expression in LUSC patients might predict better immunotherapy responses. Conclusions MRO is a critical M2 macrophage-associated gene in NSCLC, influencing immune infiltration and prognosis. It may serve as a biomarker for prognostication and a target for therapeutic intervention in NSCLC.
format Article
id doaj-art-ed7059a6c0e046a5abac73c08e903e66
institution Kabale University
issn 2730-6011
language English
publishDate 2025-01-01
publisher Springer
record_format Article
series Discover Oncology
spelling doaj-art-ed7059a6c0e046a5abac73c08e903e662025-01-26T12:40:02ZengSpringerDiscover Oncology2730-60112025-01-0116111310.1007/s12672-025-01817-8The role of MRO as an M2 macrophage-associated gene in non-small cell lung cancer: insights into immune infiltration, prognostic significance, and therapeutic implicationsYue Gu0Miaosen Zheng1Jing Xie2Department of Pathology, The People’s Hospital of RuGaoDepartment of Pathology, The People’s Hospital of RuGaoDepartment of Pathology, The People’s Hospital of RuGaoAbstract Background Non-small cell lung cancer (NSCLC), including lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), is influenced by tumor-immune interactions. M2 macrophages play a significant role in the tumor microenvironment. This study explores the role of MRO, an M2 macrophage-associated gene, in NSCLC, focusing on immune infiltration, prognostic significance, and therapeutic potential. Methods NSCLC samples from The Cancer Genome Atlas (TCGA) were analyzed using the CIBERSORT algorithm to quantify immune cell compositions. Differential gene expression and correlation studies examined MRO’s association with M2 macrophages. Univariate Cox regression and Kaplan–Meier analyses assessed prognostic significance. Single-cell RNA sequencing data from TISCH2 evaluated MRO expression in different cell types. The ESTIMATE algorithm analyzed correlations between MRO expression and immune scores, while TIDE and Submap analyses predicted immunotherapy responses. Results MRO was highly expressed in NSCLC, particularly in LUAD and LUSC, and associated with M2 macrophages. MRO correlated with key immune pathways, including TNFα signaling via NFκB, inflammatory response, and IL6 JAK STAT3 signaling. High MRO expression correlated with poorer overall survival (OS) and disease-specific survival (DSS). Single-cell analysis confirmed MRO expression in macrophages. The ESTIMATE algorithm showed positive correlations between MRO expression and immune scores. TIDE and Submap analyses suggested low MRO expression in LUSC patients might predict better immunotherapy responses. Conclusions MRO is a critical M2 macrophage-associated gene in NSCLC, influencing immune infiltration and prognosis. It may serve as a biomarker for prognostication and a target for therapeutic intervention in NSCLC.https://doi.org/10.1007/s12672-025-01817-8Non-small cell lung cancer (NSCLC)MROM2 macrophagesTumor microenvironmentImmunotherapy response
spellingShingle Yue Gu
Miaosen Zheng
Jing Xie
The role of MRO as an M2 macrophage-associated gene in non-small cell lung cancer: insights into immune infiltration, prognostic significance, and therapeutic implications
Discover Oncology
Non-small cell lung cancer (NSCLC)
MRO
M2 macrophages
Tumor microenvironment
Immunotherapy response
title The role of MRO as an M2 macrophage-associated gene in non-small cell lung cancer: insights into immune infiltration, prognostic significance, and therapeutic implications
title_full The role of MRO as an M2 macrophage-associated gene in non-small cell lung cancer: insights into immune infiltration, prognostic significance, and therapeutic implications
title_fullStr The role of MRO as an M2 macrophage-associated gene in non-small cell lung cancer: insights into immune infiltration, prognostic significance, and therapeutic implications
title_full_unstemmed The role of MRO as an M2 macrophage-associated gene in non-small cell lung cancer: insights into immune infiltration, prognostic significance, and therapeutic implications
title_short The role of MRO as an M2 macrophage-associated gene in non-small cell lung cancer: insights into immune infiltration, prognostic significance, and therapeutic implications
title_sort role of mro as an m2 macrophage associated gene in non small cell lung cancer insights into immune infiltration prognostic significance and therapeutic implications
topic Non-small cell lung cancer (NSCLC)
MRO
M2 macrophages
Tumor microenvironment
Immunotherapy response
url https://doi.org/10.1007/s12672-025-01817-8
work_keys_str_mv AT yuegu theroleofmroasanm2macrophageassociatedgeneinnonsmallcelllungcancerinsightsintoimmuneinfiltrationprognosticsignificanceandtherapeuticimplications
AT miaosenzheng theroleofmroasanm2macrophageassociatedgeneinnonsmallcelllungcancerinsightsintoimmuneinfiltrationprognosticsignificanceandtherapeuticimplications
AT jingxie theroleofmroasanm2macrophageassociatedgeneinnonsmallcelllungcancerinsightsintoimmuneinfiltrationprognosticsignificanceandtherapeuticimplications
AT yuegu roleofmroasanm2macrophageassociatedgeneinnonsmallcelllungcancerinsightsintoimmuneinfiltrationprognosticsignificanceandtherapeuticimplications
AT miaosenzheng roleofmroasanm2macrophageassociatedgeneinnonsmallcelllungcancerinsightsintoimmuneinfiltrationprognosticsignificanceandtherapeuticimplications
AT jingxie roleofmroasanm2macrophageassociatedgeneinnonsmallcelllungcancerinsightsintoimmuneinfiltrationprognosticsignificanceandtherapeuticimplications